Peptidic tools applied to redirect alternative splicing events

Peptides
Martínez-Montiel NancyMartínez-Contreras Rebeca

Abstract

Peptides are versatile and attractive biomolecules that can be applied to modulate genetic mechanisms like alternative splicing. In this process, a single transcript yields different mature RNAs leading to the production of protein isoforms with diverse or even antagonistic functions. During splicing events, errors can be caused either by mutations present in the genome or by defects or imbalances in regulatory protein factors. In any case, defects in alternative splicing have been related to several genetic diseases including muscular dystrophy, Alzheimer's disease and cancer from almost every origin. One of the most effective approaches to redirect alternative splicing events has been to attach cell-penetrating peptides to oligonucleotides that can modulate a single splicing event and restore correct gene expression. Here, we summarize how natural existing and bioengineered peptides have been applied over the last few years to regulate alternative splicing and genetic expression. Under different genetic and cellular backgrounds, peptides have been shown to function as potent vehicles for splice correction, and their therapeutic benefits have reached clinical trials and patenting stages, emphasizing the use of regulatory pepti...Continue Reading

References

Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Z Dominski, R Kole
Oct 1, 1996·Molecular Biology of the Cell·T Misteli, D L Spector
Feb 28, 1997·The Journal of Biological Chemistry·H S Bernstein, S R Coughlin
Feb 3, 1998·Biochemical and Biophysical Research Communications·N KuroyanagiM Hagiwara
Jul 22, 1998·Molecular and Cellular Biology·W SeghezziE Lees
Jul 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·W YanQ Wu
Sep 13, 2000·Antisense & Nucleic Acid Drug Development·C Ghosh, P L Iversen
Nov 22, 2001·Bioconjugate Chemistry·S FutakiY Sugiura
Mar 7, 2002·Lancet·Alan E H Emery
Mar 28, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
Aug 15, 2002·Genome Research·Juri RappsilberMatthias Mann
Sep 13, 2002·Nature·Zhaolan ZhouRobin Reed
May 4, 2004·Nature Biotechnology·Mariano A Garcia-BlancoErika L Lasda
Mar 23, 2005·Circulation·Jonathan D Sackner-BernsteinKeith D Aaronson
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Johann SoretJamal Tazi
Jun 16, 2005·Nature Reviews. Molecular Cell Biology·Arianne J MatlinChristopher W J Smith
Nov 22, 2005·Nucleic Acids Research·Jeremy E WiluszMassimo Caputi
Jul 4, 2006·Trends in Endocrinology and Metabolism : TEM·David L GarbersJohn C Burnett
Aug 11, 2006·The Journal of Gene Medicine·Samir El-AndaloussiUlo Langel
Sep 8, 2006·The Biochemical Journal·Sónia Troeira HenriquesMiguel A R B Castanho
Nov 14, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saïd AbesBernard Lebleu
Jun 21, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sue FletcherStephen D Wilton
Jun 23, 2007·Nucleic Acids Research·Saïd AbesBernard Lebleu
Jul 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samir El-AndaloussiUlo Langel
Aug 2, 2007·Expert Opinion on Biological Therapy·Fritz Eckstein
Mar 18, 2008·Biology of the Cell·May C MorrisGilles Divita
Jun 12, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Natee JearawiriyapaisarnRyszard Kole
Sep 18, 2008·Nucleic Acids Research·Rachida AbesBernard Lebleu

❮ Previous
Next ❯

Citations

Feb 15, 2018·International Journal of Molecular Sciences·Nancy Martinez-MontielRebeca Martinez-Contreras
Oct 21, 2017·Genes, Brain, and Behavior·E RebleC L Barr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Related Papers

Current Opinion in Genetics & Development
Andrea L H ArnettJeffrey S Chamberlain
Methods in Molecular Biology
Valerie T TrippDouglas D Young
© 2022 Meta ULC. All rights reserved